{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:36:50Z","timestamp":1792255010552,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umea University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rheumatoid Arthritis associated Interstitial Lung Disease (RA-ILD) is an extraarticular manifestation of rheumatoid arthritis (RA) associated with increased morbidity and mortality. Several risk factors for RA-ILD have been identified, one is the promotor variant of mucin 5 B gene (MUC5B). Juge et al., Wheeler et al. and Koduri et al. have developed risk scores for identifying patients with RA at risk of RA-ILD. We aimed to externally validate the three risk scores and further investigate the frequency of MUC5B promotor variant and its association with subclinical lung changes in patients with RA in northern Sweden. Our cohort consisted of 54 patients with RA. The risk score variables were evaluated in binary logistic regression and validated using area under the receiver operating characteristics curve (AUC ROC). The genetic material was purified and genotyped for MUC5B. The Juge et al. risk score performed an AUC ROC of 0.71 (95% CI 0.57;0.86), the Wheeler et al. risk score an AUC ROC of 0.75 (95% CI 0.59;0.90) and Koduri et al. risk score an AUC ROC of 0.70 ((95% CI 0.55;0.85) in our cohort. The differences in AUC were not statistically significant. The MUC5B promotor variant frequency was 26% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200914). In our cohort, MUC5B was not significantly associated with subclinical lung changes. The three externally validated risk scores for RA-ILD performed well in this cohort and could be used clinically. In patients with RA in northern Sweden, MUC5B was not found to be independently associated with subclinical RA-ILD.\n                  <\/jats:p>","DOI":"10.1007\/s00296-025-06005-z","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T06:57:54Z","timestamp":1760511474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparable area under the curve for three risk scores to detect interstitial lung disease in patients with rheumatoid arthritis: an external validation"],"prefix":"10.1007","volume":"45","author":[{"given":"Elin","family":"Blomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-2326","authenticated-orcid":false,"given":"Bengt","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-7900","authenticated-orcid":false,"given":"Anna","family":"S\u00f6dergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"6","key":"6005_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS (2023) Rheumatoid Arthritis - Common Origins, divergent mechanisms. N Engl J Med 388(6):529\u2013542. https:\/\/doi.org\/10.1056\/NEJMra2103726","journal-title":"N Engl J Med"},{"issue":"4","key":"6005_CR2","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"issue":"10","key":"6005_CR3","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67(10):1488\u20131492. https:\/\/doi.org\/10.1136\/ard.2007.075192","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"6005_CR4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E, Ellingsen T (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76(10):1700\u20131706. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6005_CR5","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","volume":"21","author":"M Akiyama","year":"2022","unstructured":"Akiyama M, Kaneko Y (2022) Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev 21(5):103056. https:\/\/doi.org\/10.1016\/j.autrev.2022.103056","journal-title":"Autoimmun Rev"},{"issue":"4","key":"6005_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10067-020-05320-z","volume":"40","author":"Y Dai","year":"2021","unstructured":"Dai Y, Wang W, Yu Y, Hu S (2021) Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Clin Rheumatol 40(4):1211\u20131220. https:\/\/doi.org\/10.1007\/s10067-020-05320-z","journal-title":"Clin Rheumatol"},{"issue":"3","key":"6005_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1378\/chest.13-2408","volume":"145","author":"TJ Doyle","year":"2014","unstructured":"Doyle TJ, Lee JS, Dellaripa PF, Lederer JA, Matteson EL, Fischer A, Ascherman DP, Glassberg MK, Ryu JH, Danoff SK et al (2014) A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease. Chest 145(3):454\u2013463. https:\/\/doi.org\/10.1378\/chest.13-2408","journal-title":"Chest"},{"key":"6005_CR8","doi-asserted-by":"publisher","first-page":"872120","DOI":"10.1155\/2011\/872120","volume":"2011","author":"MJ Hamblin","year":"2011","unstructured":"Hamblin MJ, Horton MR (2011) Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med 2011:872120. https:\/\/doi.org\/10.1155\/2011\/872120","journal-title":"Pulm Med"},{"issue":"160","key":"6005_CR9","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G (2021) Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respiratory Review: Official J Eur Respiratory Soc 30(160):210011. https:\/\/doi.org\/10.1183\/16000617.0011-2021","journal-title":"Eur Respiratory Review: Official J Eur Respiratory Soc"},{"issue":"8","key":"6005_CR10","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1007\/s10238-023-01202-1","volume":"23","author":"A Poerio","year":"2023","unstructured":"Poerio A, Carlicchi E, Zompatori M (2023) Diagnosis of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) and rheumatoid arthritis (RA) and identification of \u2018progressive pulmonary fibrosis\u2019 using chest CT: a narrative review. Clin Exp Med 23(8):4721\u20134728. https:\/\/doi.org\/10.1007\/s10238-023-01202-1","journal-title":"Clin Exp Med"},{"issue":"23","key":"6005_CR11","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S et al (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med 379(23):2209\u20132219. https:\/\/doi.org\/10.1056\/NEJMoa1801562","journal-title":"N Engl J Med"},{"key":"6005_CR12","doi-asserted-by":"publisher","first-page":"152098","DOI":"10.1016\/j.semarthrit.2022.152098","volume":"57","author":"AM Wheeler","year":"2022","unstructured":"Wheeler AM, Baker JF, Poole JA, Ascherman DP, Yang Y, Kerr GS, Reimold A, Kunkel G, Cannon GW, Wysham KD et al (2022) Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease. Semin Arthritis Rheum 57:152098. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152098","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 3","key":"6005_CR13","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1513\/AnnalsATS.201802-144AW","volume":"15","author":"DA Schwartz","year":"2018","unstructured":"Schwartz DA (2018) Idiopathic pulmonary fibrosis is a genetic disease involving mucus and the peripheral airways. Ann Am Thorac Soc 15(Suppl 3):S192\u2013s197. https:\/\/doi.org\/10.1513\/AnnalsATS.201802-144AW","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"6005_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.42162","volume":"74","author":"PA Juge","year":"2022","unstructured":"Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B et al (2022) A risk score to detect subclinical rheumatoid Arthritis-Associated interstitial lung disease. Arthritis Rheumatol 74(11):1755\u20131765. https:\/\/doi.org\/10.1002\/art.42162","journal-title":"Arthritis Rheumatol"},{"key":"6005_CR15","doi-asserted-by":"crossref","unstructured":"Wheeler AM, Baker JF, Riley T, Yang Y, Roul P, Wysham KD, Cannon GW, Kunkel G, Kerr G, Ascherman DP et al (2024) Development and Internal Validation of a Clinical and Genetic Risk Score for Rheumatoid Arthritis-Associated Interstitial Lung Disease. Rheumatology (Oxford). 2025;64(1):268\u2013275. 10.1093\/ rheumatology\/keae001","DOI":"10.1093\/rheumatology\/keae001"},{"key":"6005_CR16","doi-asserted-by":"publisher","unstructured":"Koduri GM, Podlasek A, Pattapola S, Zhang J, Laila D, Nandagudi A, Dubey S, Kelly C (2023) Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis. Rheumatol Int 1515\u20131523. https:\/\/doi.org\/10.1007\/s00296-023-05313-6","DOI":"10.1007\/s00296-023-05313-6"},{"issue":"2","key":"6005_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/03009742.2019.1657491","volume":"49","author":"K H\u00f6rnberg","year":"2020","unstructured":"H\u00f6rnberg K, Pomeroy J, Sandberg C, S\u00f6dergren A, \u00c5ngstr\u00f6m L, Sundstr\u00f6m B, W\u00e5llberg Jonsson S (2020) Physical activity in rheumatoid arthritis: relationship to cardiovascular risk factors, subclinical atherosclerosis, and disease activity. Scand J Rheumatol 49(2):112\u2013121. https:\/\/doi.org\/10.1080\/03009742.2019.1657491","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"6005_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/acr2.11225","volume":"3","author":"K H\u00f6rnberg","year":"2021","unstructured":"H\u00f6rnberg K, Pomeroy J, Sandberg C, \u00c5ngstr\u00f6m L, S\u00f6dergren A, Sundstr\u00f6m B (2021) Isotemporal substitution of time between sleep and physical activity: associations with cardiovascular risk factors in early rheumatoid arthritis. ACR Open Rheumatol 3(3):138\u2013146. https:\/\/doi.org\/10.1002\/acr2.11225","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"6005_CR19","doi-asserted-by":"publisher","first-page":"e1833","DOI":"10.1002\/pri.1833","volume":"25","author":"L \u00c5ngstr\u00f6m","year":"2020","unstructured":"\u00c5ngstr\u00f6m L, H\u00f6rnberg K, Sundstr\u00f6m B, Jonsson SW, S\u00f6dergren A (2020) Aerobic capacity is associated with disease activity and cardiovascular risk factors in early rheumatoid arthritis. Physiother Res Int 25(3):e1833. https:\/\/doi.org\/10.1002\/pri.1833","journal-title":"Physiother Res Int"},{"issue":"1","key":"6005_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/03009742.2021.1973678","volume":"52","author":"L \u00c5ngstr\u00f6m","year":"2023","unstructured":"\u00c5ngstr\u00f6m L, H\u00f6rnberg K, Sundstr\u00f6m B, S\u00f6dergren A (2023) Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables. Scand J Rheumatol 52(1):10\u201316. https:\/\/doi.org\/10.1080\/03009742.2021.1973678","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"6005_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al (2010) 2010 rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6005_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348. 10.1002\/ art.1780380107","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6005_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/03009748809098795","volume":"17","author":"C Ekdahl","year":"1988","unstructured":"Ekdahl C, Eberhardt K, Andersson SI, Svensson B (1988) Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford health assessment questionnaire. Scand J Rheumatol 17(4):263\u2013271. https:\/\/doi.org\/10.3109\/03009748809098795","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"6005_CR24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL (2009) Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954\u2013960. https:\/\/doi.org\/10.1136\/ard.2007.084459","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6005_CR25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.acra.2019.06.019","volume":"27","author":"J Vikgren","year":"2020","unstructured":"Vikgren J, Khalil M, Cederlund K, S\u00f6rensen K, Boijsen M, Brandberg J, Lampa E, Sk\u00f6ld MC, Wollmer P, Lindberg E et al (2020) Visual and quantitative evaluation of emphysema: A Case-Control study of 1111 participants in the pilot Swedish cardiopulmonary bioimage study (SCAPIS). Acad Radiol 27(5):636\u2013643. https:\/\/doi.org\/10.1016\/j.acra.2019.06.019","journal-title":"Acad Radiol"},{"issue":"4","key":"6005_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26(4):720\u2013735. https:\/\/doi.org\/10.1183\/09031936.05.00034905","journal-title":"Eur Respir J"},{"issue":"3","key":"6005_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03009738609178670","volume":"91","author":"H Hedenstr\u00f6m","year":"1986","unstructured":"Hedenstr\u00f6m H, Malmberg P, Fridriksson HV (1986) Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci 91(3):299\u2013310. https:\/\/doi.org\/10.3109\/03009738609178670","journal-title":"Ups J Med Sci"},{"key":"6005_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-418687-3.00023-9","volume":"529","author":"JS Dymond","year":"2013","unstructured":"Dymond JS (2013) Explanatory chapter: quantitative PCR. Methods Enzymol 529:279\u2013289. https:\/\/doi.org\/10.1016\/B978-0-12-418687-3.00023-9","journal-title":"Methods Enzymol"},{"key":"6005_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00296-025-05955-8","volume":"45","author":"DT Karadag","year":"2025","unstructured":"Karadag DT, Gokcen N, Yazici A et al (2025) Approaches to screening for rheumatoid arthritis-associated interstitial lung disease: a cross-sectional National survey of Turkish rheumatologists. Rheumatol Int 45:187. https:\/\/doi.org\/10.1007\/s00296-025-05955-8","journal-title":"Rheumatol Int"},{"issue":"1","key":"6005_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS (2022) Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1):25\u201336. https:\/\/doi.org\/10.4097\/kja.21209","journal-title":"Korean J Anesthesiol"},{"issue":"1","key":"6005_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/nur.10015","volume":"25","author":"PA Patrician","year":"2002","unstructured":"Patrician PA (2002) Multiple imputation for missing data. Res Nurs Health 25(1):76\u201384. https:\/\/doi.org\/10.1002\/nur.10015","journal-title":"Res Nurs Health"},{"key":"6005_CR32","doi-asserted-by":"publisher","unstructured":"Joo YB, Ahn SM, Bang SY, Park Y, Hong SJ, Lee Y, Cho SK, Choi CB, Sung YK, Kim TH et al (2022) MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations. RMD Open 8(2). https:\/\/doi.org\/10.1136\/rmdopen-2022-002790","DOI":"10.1136\/rmdopen-2022-002790"},{"issue":"8","key":"6005_CR33","doi-asserted-by":"publisher","first-page":"e104919","DOI":"10.1371\/journal.pone.0104919","volume":"9","author":"C Wang","year":"2014","unstructured":"Wang C, Zhuang Y, Guo W, Cao L, Zhang H, Xu L, Fan Y, Zhang D, Wang Y (2014) Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males. PLoS ONE 9(8):e104919. https:\/\/doi.org\/10.1371\/journal.pone.0104919","journal-title":"PLoS ONE"},{"key":"6005_CR34","doi-asserted-by":"publisher","unstructured":"Matson SM, Deane KD, Peljto AL, Bang TJ, Sachs PB, Walts AD, Collora C, Ye S, Demoruelle MK, Humphries SM et al (2022) Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the MUC5B Promoter Variant. Am J Respir Crit Care Med 205(4):473\u2013476. oi: https:\/\/doi.org\/10.1164\/rccm.202109-2087LE","DOI":"10.1164\/rccm.202109-2087LE"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-06005-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:12:31Z","timestamp":1763615551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-06005-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6005"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-06005-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"252"}}